Advisory Council January 2018 Meeting Presentation: Participating in an Alzheimer's Clinical Study

01/26/2018

ADVISORY COUNCIL ON ALZHEIMER'S RESEARCH, CARE, AND SERVICES

Friday, January 26, 2018

Printer Friendly Version in PDF Format (5 PDF pages)

 

Participating in an Alzheimer's Clinical Study: Perspectives on Involvement of a Person Living with Dementia and Her Study Partner.

Cynthia Huling Hummel B.S., MDiv, D.Min. & Marion D. Weisse BSN, M.Ed.

Participating in Alzheimer's Clinical research...

  • May provide PLWDs with hope and strength.
  • May help those living with a dementia diagnosis to move from feeling like victims to feeling like champions: from "Why Me to What Next"
  • May not benefit the PLWD, but may benefit her heirs.
  • May give our lives a purpose. We leave behind a legacy!
  • Provides excellent medical care and access to procedures not yet available to general public.
  • Will lead to treatments and to a cure!

Requirements of an ADNI3 Study Partner:

  • Must have direct contact with the subject at least one day (a minimum average of 10 hours per week.)
  • Must be able to accompany the subject to all clinic visits or be available via phone to answer questions from study staff.
  • Provide general information such as age, gender as well as relationship to the participant. Study partners will also be asked questions about the participant's health, memory, thinking function and emotional well-being in order to learn about changes in the participant.

Adventures and Challenges

 

New Study Considerations: Possibilities vs. Challenges

  • Observational vs interventional study? Benefits vs. risks
  • Distance from testing site. Should I move in order to participate?
  • What if my current study partner isn't able to participate in a more demanding study?
  • Should I participate in a study when I am no longer able to consent or able to work out the logistics? Another consideration: the time commitment.

FULL EXPANDED LIST OF 2016 NAPA RECOMMENDATIONS

  • A major area of emphasis for the 2017 National Plan should include the enhancement of recruitment efforts for randomized controlled trials for AD/ADRD
  • A major challenge in the development of effective therapies for AD/ADRD has been the inefficient recruitment of participants in clinical trials.
  • Emphasis should be placed on the enhancement of diversity and inclusiveness in these efforts.

Think Outside the Box To Reduce Obstacles to Participation

  • Encourage PCP's to provide the newly diagnosed (and care partners) with information on the benefits of enrolling in clinical studies.
  • Use faith communities to promote studies and host field research.
  • Send researchers into the field (think Bookmobile).
  • Provide vouchers for those in need to cover hotel, food and transportation costs.
  • Promote non-familial study partners.

Additional recommendations

  • Encourage Open House enrollment days at study sites (swabbing parties)
  • Provide accommodations through technology
  • Make appointment times convenient for PLWD and Study partner
  • Develop outreach materials/education for diagnosing clinicians to help refer.

References:


Return to

National Alzheimer's Project Act Home Page

Advisory Council on Alzheimer's Research, Care, and Services Page

Advisory Council on Alzheimer's Research, Care, and Services Meetings Page